- Home
- / Mirada Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Mirada Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Total Funding
$566.5 K
Revenue
£3.9 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 4.7M | 3.9M | |
| Cost of goods sold | 220.6K | 360.1K | |
| Gross profit | 4.4M | 3.5M | |
| Gross profit margin, % | 95.3% | 90.7% | |
| General and administrative expense | 8.0M | 8.0M | |
| Operating expense total | 8.0M | 8.0M | |
| Depreciation and amortization | 612.6K | ||
| EBIT | (3.9M) | (4.8M) | |
| EBIT margin, % | -82.5% | -124.1% | |
| Interest income | 6.3K | ||
| Interest expense | 33.3K | 1.7K | |
| Pre tax profit | (3.6M) | (4.8M) | |
| Income tax expense | 690.8K | 746.0K | |
| Net Income | (2.9M) | (4.0M) | (5.3M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |